Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dare Bioscience (DARE) Free Cash Flow (2016 - 2025)

Dare Bioscience's Free Cash Flow history spans 11 years, with the latest figure at $1.1 million for Q4 2025.

  • For Q4 2025, Free Cash Flow fell 78.01% year-over-year to $1.1 million; the TTM value through Dec 2025 reached -$10.3 million, down 306.52%, while the annual FY2025 figure was -$10.3 million, 306.52% down from the prior year.
  • Free Cash Flow reached $1.1 million in Q4 2025 per DARE's latest filing, up from -$99938.0 in the prior quarter.
  • In the past five years, Free Cash Flow ranged from a high of $12.6 million in Q2 2024 to a low of -$16.1 million in Q1 2023.
  • Average Free Cash Flow over 5 years is -$4.6 million, with a median of -$6.2 million recorded in 2022.
  • Peak YoY movement for Free Cash Flow: soared 554.4% in 2022, then tumbled 193.57% in 2023.
  • A 5-year view of Free Cash Flow shows it stood at -$9.9 million in 2021, then soared by 40.51% to -$5.9 million in 2022, then plummeted by 48.94% to -$8.8 million in 2023, then skyrocketed by 154.81% to $4.8 million in 2024, then tumbled by 78.01% to $1.1 million in 2025.
  • Per Business Quant, the three most recent readings for DARE's Free Cash Flow are $1.1 million (Q4 2025), -$99938.0 (Q3 2025), and -$5.6 million (Q2 2025).